Hepatic ultrasound findings in the glycogen storage diseases.
Hepatic ultrasonography was performed on 70 patients with the hepatic glycogen storage diseases (GSDs) to assess parenchymal echogenicity. 27 patients had GSD-I, 24 had GSD-III and 19 had GSDs-VI/IX; ages varied from 0.6 to 35.7 years (median 11.7). 31 (44%) had normal or mild parenchymal changes, and 41% (11/27) of those with GSD-I, 25% (6/24) with GSD-III and 11% (2/19) with GSDs-VI/IX had marked changes. No relationships were found between the ultrasonographic appearances and other indices of metabolic control, including plasma triglycerides, total cholesterol or height standard deviation score. Seven adult patients (21-29 years) were found to have hepatic tumours: six with GSD-I and one with GSD-III. Those with GSD-I and tumours tended to have the more severe hepatic parenchymal changes. We conclude that ultrasonography may be useful in identifying patients with GSD-I at risk of hepatic tumour formation.
Lee
P
P
Medical Unit Institute of Child Health, Hospital for Sick Children, London, UK.
Mather
S
S
Owens
C
C
Leonard
J
J
Dicks-Mireaux
C
C
D000236:Adenoma / Q000000981:diagnostic imaging; D000293:Adolescent; D000328:Adult; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D005260:Female; D006008:Glycogen Storage Disease / Q000000981:diagnostic imaging*; D005953:Glycogen Storage Disease Type I / Q000097:blood / Q000000981:diagnostic imaging; D006010:Glycogen Storage Disease Type III / Q000097:blood / Q000000981:diagnostic imaging; D006013:Glycogen Storage Disease Type VI / Q000097:blood / Q000000981:diagnostic imaging; D006801:Humans; D007223:Infant; D008099:Liver / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D008297:Male; D014463:Ultrasonography